Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 5708
  • 5709
  • 5710
  • …
  • ›
  • »

2026-04-07

Intrepid Metals Corp.: Intrepid Metals Raises Over C$6 Million Through Strong Warrant Exercise Participation

2026-04-07

NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026

2026-04-07

Asbury Automotive Group Schedules Release of First Quarter 2026 Financial Results

2026-04-07

Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center

2026-04-07

Hydrogen Utopia seeks Powerhouse licence, says Europe demand growing

2026-04-07

IN BRIEF: Beeks Financial wins PS2 million Proximity Cloud contract

2026-04-07

Breedon calls for clarity on UK carbon import control scheme

2026-04-07

AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly

2026-04-07

Stepan to Announce First Quarter 2026 Results on April 28, 2026

2026-04-07

Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System

2026-04-07

Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development

2026-04-07

Invitation to Conference Call – Interim Report Byggmax Group January 1 – March 31, 2026

  • «
  • ‹
  • …
  • 5708
  • 5709
  • 5710
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies